Hepatoma Research
All Journals
Search Log In
Editor-in-Chief: Guang-Wen Cao
Indexing: ESCI, CAS, Scopus, Wanfang Data, CNKI, Dimensions, Embase, ASCI,
Journal Rank: CiteScore 3.5 - Impact Factor 1.2, Q3 (Gastroenterology & Hepatology)
Median time to first editorial decision: 10 days
Home Articles Special Topics Volumes Webinars Videos
Hepatoma Research
Search Submit
Editor-in-Chief: Guang-Wen Cao
Journal Rank: CiteScore 3.5 - Impact Factor 1.2, Q3 (Gastroenterology & Hepatology)
Median time to first editorial decision: 10 days
Home Articles Special Topics Volumes Webinars Videos

Hepatoma Research

Hepatocellular carcinoma surveillance: current practice and future directions

Histopathology of hepatocellular carcinoma - when and what

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Liver Transplantation for perihilar cholangiocarcinoma. Do we need to move forward?

Articles

Most Recent | Most Viewed | Most Downloaded

Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma

Yang Wang, ...Xin-Rong Yang
Open Access Review DOI: 10.20517/2394-5079.2025.105 1 Jun 2026
Views: Downloads:
Download PDF

Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions

Bailey Hall, ...Jon Davidson
Open Access Review DOI: 10.20517/2394-5079.2025.70 29 May 2026
Views: Downloads:
Download PDF

Patient-derived tumor organoid models for functional precision oncology in hepatocellular carcinoma

Lu Han, ...Fei Song
Open Access Review DOI: 10.20517/2394-5079.2025.118 25 May 2026
Views: Downloads:
Download PDF

Conversion and neoadjuvant systemic therapy for intrahepatic cholangiocarcinoma: from technical resectability to biology-driven surgical selection - a systematic review and meta-analysis

Luca Risi, ...Luca Viganò
Open Access Meta-Analysis DOI: 10.20517/2394-5079.2025.85 15 May 2026
Views: Downloads:
Download PDF

Resistance to immune checkpoint inhibitors in hepatocellular carcinoma: mechanisms and combination strategies to overcome it

Tingjiang He, ...Qianwei Zhao
Open Access Review DOI: 10.20517/2394-5079.2025.74 14 May 2026
Views: Downloads:
Download PDF

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease

Carmen Colaci, ... Ludovico AbenavoliLudovico Abenavoli
Open Access Review DOI: 10.20517/2394-5079.2023.134 28 Mar 2024
Views: Downloads:
Download PDF

Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer

Anjali SinghAnjali Singh, ... Narsingh Verma
Open Access Review DOI: 10.20517/2394-5079.2024.88 29 Oct 2024
Views: Downloads:
Download PDF

Pathophysiology of liver cirrhosis and risk correlation between immune status and the pathogenesis of hepatocellular carcinoma

Manaf AlsudaneyManaf Alsudaney, ... Ju Dong Yang
Open Access Review DOI: 10.20517/2394-5079.2024.141 19 Feb 2025
Views: Downloads:
Download PDF

Hepatocellular Carcinoma, Microbiome, and Epigenetics

Prof. Jun Yu; Prof. Ming Kuang; Prof. Lixia Xu

Submission Deadline: 30 Sep 2026

Published articles: 0

Fibrosis Driven Hepatocarcinogenesis in MASLD/MASH: Mechanisms, Biomarkers and Therapeutic Horizons

Prof. Ralf Weiskirchen

Submission Deadline: 31 Aug 2026

Published articles: 0

Coming soon.

For Reviewers

Peer Review Guidelines
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Themed Collections
Hepatocellular carcinoma
HCC
Liver Cancer
Liver tumors
Hepatoblastoma
Cholangiocarcinoma
Nonalcoholic fatty liver disease
Nonalcoholic steatohepatitis
Hepatitis B; Hepatitis C
Immunotherapy
Systemic treatment
Liver transplantation
Liver resection
Surgical
Management
Surveillance
Epidemiology
Molecular mechanisms
Tumor microenvironment
Biomarker
Stem cell
Topic: Surgical Resection for HCC: Insights into the Indications and the Prognosis
Topic: Systemic Therapy for Advanced Cholangiocarcinoma: New Options on the Horizon
Topic: Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
Volume 11 (2025)
Volume 10 (2024)
Volume 9 (2023)
Volume 8 (2022)
Volume 7 (2021)
Volume 6 (2020)
Volume 5 (2019)
Volume 4 (2018)
Volume 3 (2017)
Volume 2 (2016)
Volume 1 (2015)
Related Journals

Journal of Cancer Metastasis and Treatment

Metabolism and Target Organ Damage

Editor-in-Chief: Amedeo Lonardo, Youfei Guan
AMMF's Hybrid 2024 European Cholangiocarcinoma Conference
Congratulations to Hepatoma Research Editorial Board Members Listed among the World's Top 2% Scientists 2025
Hepatoma Research Editorial Board Members Achieve Outstanding Presence in the World's Top 2% Scientists List
Partner with ILCA Annual Conference 2025
Advancing Liver Cancer Research Together – ILCA 2025
In-Depth Interview with Prof. Jeong Min Lee
Distinguished Member of the Korean Academy of Science and Technology
Hepatoma Research CiteScore 2024: 3.5
Hepatoma Research Achieves Significant Increase with a 2024 CiteScore of 3.5!
Hepatoma Research 2024 Best Paper Awards
The Selection Committee of Hepatoma Research has identified five papers as exemplary contributions

Hepatocellular carcinoma surveillance: current practice and future directions

Histopathology of hepatocellular carcinoma - when and what

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Liver Transplantation for perihilar cholangiocarcinoma. Do we need to move forward?

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
Carmen Colaci, ... Ludovico AbenavoliLudovico Abenavoli
Open Access | Review | 28 Mar 2024
Views: | Downloads:
Download PDF
Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer
Anjali SinghAnjali Singh, ... Narsingh Verma
Open Access | Review | 29 Oct 2024
Views: | Downloads:
Download PDF
Pathophysiology of liver cirrhosis and risk correlation between immune status and the pathogenesis of hepatocellular carcinoma
Manaf AlsudaneyManaf Alsudaney, ... Ju Dong Yang
Open Access | Review | 19 Feb 2025
Views: | Downloads:
Download PDF

Hepatocellular Carcinoma, Microbiome, and Epigenetics

Prof. Jun Yu; Prof. Ming Kuang; Prof. Lixia Xu

Submission Deadline: 30 Sep 2026

Published articles: 0

Fibrosis Driven Hepatocarcinogenesis in MASLD/MASH: Mechanisms, Biomarkers and Therapeutic Horizons

Prof. Ralf Weiskirchen

Submission Deadline: 31 Aug 2026

Published articles: 0

Related Journals

Journal of Cancer Metastasis and Treatment

Metabolism and Target Organ Damage

Editor-in-Chief: Amedeo Lonardo, Youfei Guan

Coming soon.

Volume 11 (2025)
Volume 10 (2024)
Volume 9 (2023)
Volume 8 (2022)
Volume 7 (2021)
Volume 6 (2020)
Volume 5 (2019)
Volume 4 (2018)
Volume 3 (2017)
Volume 2 (2016)
Volume 1 (2015)
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2026 OAE Publishing Inc., except certain content provided by third parties